At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Device: Contour Next and Contour Plus Elite BGMS testing of arterial blooddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Performance of Contour Next® and Contour Plus Elite® Blood Glucose Monitoring Systems (BGMS) in Arterial Blood Samples From Hospitalized Adults
In Brief
An observational study evaluating Device: Contour Next and Contour Plus Elite BGMS testing of arterial blood for Diabetes Mellitus. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesAustralia
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJul 2022
Enrollment StartNov 2022
Primary CompletionFeb 2023
Study CompletionApr 2023
TodayJul 2026
First PostedJul 8, 2022
Enrollment StartNov 29, 2022
Primary CompletionFeb 2, 2023
Study CompletionApr 20, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.0 years ago
Interventions
Device: Contour Next and Contour Plus Elite BGMS testing of arterial blooddevice
The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.